Identification | Back Directory | [Name]
2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | [CAS]
1415566-28-7 | [Synonyms]
Rivaroxaban-3 Rivaroxaban ImpIII Dechloro Rivaroxaban Rivaroxaban Impurity ⅢA Rivaroxaban impurity P3-L Rivaroxaban EP Impurity E Rivaroxyban des chloro imp Rivaroxaban deschloro crude Rivaroxaban Dechloro Impurity Rivaroxaban Deschloro Impurity Rivaroxyban- Des chloro impurity Rivaroxaban impurity C: dechlorinated Rivaroxaban Impurity 3(Deschloro Rivaroxaban) Rivaroxaban Impurity D/ Rivaroxaban Deschloro Impurity Rivaroxaban EP Impurity E/Rivaroxaban Deschloro Impurity N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide 5-chloro-N,N-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl) oxazolidin-5-yl)methyl)thiophene-2-carboxamide Imp. A :(S)-N-((2-oxo-3-(4-(2-oxo-1,3-oxazinan-3-yl)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide Rivaroxaban impurity 3/
Dechloro-Rivaroxaban/N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | [Molecular Formula]
C19H19N3O5S | [MDL Number]
MFCD31654721 | [MOL File]
1415566-28-7.mol | [Molecular Weight]
401.44 |
Chemical Properties | Back Directory | [Melting point ]
216 - 218°C | [Boiling point ]
758.0±60.0 °C(Predicted) | [density ]
1.400±0.06 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly, Heated), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
13.73±0.46(Predicted) | [color ]
White to Off-White |
Hazard Information | Back Directory | [Uses]
Dechloro-Rivaroxaban is an impurity of Rivaroxaban (R538000), which is a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor. |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
|